High Prevalence of Hormonal Changes and Hepatic Osteodystrophy in Frail Patients with Cirrhosis-An Observational Study.
J Clin Exp Hepatol
; 12(3): 800-807, 2022.
Article
em En
| MEDLINE
| ID: mdl-35677501
ANOVA, analysis of variance; BMD, bone mineral density; BMI, body mass index; CI, confidence interval; CRP, C-reactive protein; CTP, ChildTurcottePugh; DEXA, dual-energy X-ray absorptiometry; ESR, erythrocyte sedimentation rate; HCC, hepatocellular carcinoma; HE, hepatic encephalopathy; IBM, International Business Machines; LFI, Liver Frailty Index; MAC, mid-arm circumference; MAMC, mid-arm muscle circumference; MELD, model for end-stage liver disease; MELDNa, model for end-stage liver disease with sodium; NASH, non-alcoholic steatohepatitis; P1-NP, procollagen type 1 N-terminal propeptide; PTH, parathyroid Hormone; SGA, subjective global assessment; SPSS, Statistical Package for Social Sciences; T3, triiodothyronine; T4, tetraiodothyronine; TIBC, total iron-binding capacity; TSF, triceps skin-fold thickness; TSH, thyroid stimulating hormone; cirrhosis; frailty; hormonal changes; osteodystrophy
Texto completo:
1
Coleções:
01-internacional
Temas:
Geral
Base de dados:
MEDLINE
Tipo de estudo:
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Idioma:
En
Revista:
J Clin Exp Hepatol
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Índia